Free Practice Questions for Lebanon Pharmacy Colloquium
Exam-style questions and explanations by OpenExamPrep.
Loading practice questions...
Explore More Lebanese Healthcare Colloquium Licensing Examinations (MEHE / MOPH)
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
Key Facts: Lebanon Pharmacy Colloquium Exam
Written + Oral + Practical
Examination Components
Decree No. 9276, Art. 5
12/20
Pass Mark (Written and Overall)
Decree No. 9276, Art. 5
2 Sessions
Annual Exam Sittings
DGHE Colloquium circulars
OPL License
Professional Licensing
Order of Pharmacists of Lebanon
EN & FR
Delivery Languages
MEHE DGHE Policies
Lebanese University
Body Conducting the Examination
Decree No. 9276, Art. 4
The Lebanese Pharmacy Colloquium is the national licensing examination required for a practice licence from the Ministry of Public Health and registration with the Order of Pharmacists of Lebanon (OPL). Organised by MEHE/DGHE with MOPH and conducted by the Lebanese University, it comprises written, oral and practical components under Decree No. 9276, which sets a 12/20 pass threshold and a practical-component floor of 8/20. Tested areas span pharmacology, pharmacotherapy, clinical pharmacy, pharmaceutics and pharmacy law. This bank offers 100 English-language study questions covering the written component's knowledge base.
Sample Lebanon Pharmacy Colloquium Practice Questions
Try these sample questions to review concepts for the Lebanon Pharmacy Colloquium exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.
1A 64-year-old male with symptomatic heart failure with reduced ejection fraction (HFrEF, LVEF 28%, NYHA Class III) is being discharged from the hospital. He is currently taking furosemide 40 mg PO daily and carvedilol 12.5 mg PO BID. Laboratory results show serum potassium 4.2 mEq/L, eGFR 58 mL/min/1.73m², and blood pressure 118/74 mmHg. According to international and Lebanese clinical guidelines for guideline-directed medical therapy (GDMT), which of the following represents the most appropriate regimen to optimize the four foundational pillars of HFrEF mortality reduction?
2A 52-year-old female with type 2 diabetes mellitus is newly diagnosed with stage 1 hypertension (BP 138/88 mmHg confirmed on repeated visits). Urinalysis reveals persistent microalbuminuria with a urinary albumin-to-creatinine ratio (UACR) of 180 mg/g. Which of the following antihypertensive drug classes is considered the first-line therapy of choice due to its proven nephroprotective benefits?
3A 58-year-old male with chronic non-valvular atrial fibrillation undergoes mechanical mitral valve replacement. His cardiologist asks the clinical pharmacist regarding oral anticoagulation therapy. Which of the following regimens is strictly indicated in this patient?
4A 60-year-old male is admitted with an acute non-ST-elevation myocardial infarction (NSTEMI) and undergoes successful percutaneous coronary intervention (PCI) with a drug-eluting stent. His baseline fasting lipid panel shows LDL-C of 145 mg/dL. According to dyslipidemia clinical practice guidelines for clinical atherosclerotic cardiovascular disease (ASCVD), which lipid-lowering regimen should be initiated prior to hospital discharge?
5A 55-year-old woman presents to the community pharmacy with a headache. Her blood pressure is measured at 195/115 mmHg. She has no chest pain, shortness of breath, neurological deficits, visual changes, or nausea. What key clinical feature distinguishes a hypertensive emergency from hypertensive urgency, and what is the appropriate pharmaceutical care approach for this patient?
6A 34-year-old previously healthy male with no significant medical history and no recent antibiotic exposure presents to an ambulatory clinic with fever, productive cough, and right lower lobe consolidation confirmed by chest X-ray. He is diagnosed with community-acquired pneumonia (CAP) suitable for outpatient treatment. According to clinical guidelines (ATS/IDSA), which of the following is the first-line oral empirical monotherapy of choice?
7A 24-year-old non-pregnant female presents to the pharmacy complaining of burning on urination (dysuria), urinary frequency, and urgency for the past 24 hours. She has no fever, flank pain, vaginal discharge, or prior history of urinary tract infections. Which of the following oral regimens represents a first-line treatment for acute uncomplicated cystitis?
8A 68-year-old hospitalized patient develops hospital-acquired pneumonia (HAP) 5 days after admission. Sputum Gram stain reveals Gram-negative bacilli, and empirical therapy against Pseudomonas aeruginosa is required. Which of the following beta-lactam antibiotics lacks antipseudomonal activity and would be INAPPROPRIATE for this patient?
9A clinical pharmacist reviews the mechanism of action of vancomycin used in the management of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. By which specific molecular mechanism does vancomycin inhibit bacterial cell wall synthesis?
10A blood culture from a septic patient grows Klebsiella pneumoniae producing an Extended-Spectrum Beta-Lactamase (ESBL). According to microbiological and clinical trial evidence (e.g., the MERINO trial), which antibiotic class represents the definitive first-line treatment of choice for severe bloodstream infections caused by ESBL-producing Enterobacterales?
About the Lebanon Pharmacy Colloquium Exam
The Lebanon Pharmacy Colloquium (Colloque de Pharmacie / امتحان الكولوكيوم في الصيدلة) is the national licensing examination that pharmacy graduates must pass to practise in Lebanon. Law No. 367/1994 (Art. 3) makes success in the Colloquium — conducted by the ministry responsible for higher education — a statutory condition of the pharmacy practice licence, and Decree No. 9276 of 5 October 1996 applies the examination to graduates of faculties operating in Lebanon and abroad without exception. Art. 5 of that decree sets three components for pharmacy: a written examination, an oral examination and a practical examination. Tested areas include pharmacology and disease-state pharmacotherapy, clinical pharmacy interventions, adverse drug reaction monitoring, dosage form design and stability, biopharmaceutics and pharmacokinetics, medicinal chemistry, natural products, and Lebanese pharmacy law and ethics. The 2026 Directorate General of Higher Education notice confirmed that Colloquium examinations are held in French or English only. This bank is an independent English-language MCQ study adaptation by OpenExamPrep; it supports the knowledge tested on the written paper and is not a substitute for the oral and practical components.
Exam sponsor: Directorate General of Higher Education (MEHE) & Ministry of Public Health (MOPH) in coordination with the Order of Pharmacists of Lebanon (OPL). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.
Assessment
The Lebanese Pharmacy Colloquium (Colloque de Pharmacie) is organised by the Ministry of Education and Higher Education with the Ministry of Public Health, and conducted by the Lebanese University Faculty of Pharmacy under Decree No. 9276 (Art. 4). It runs in two sessions per year (first and second session) whose dates are fixed by DGHE circular; for 2026, first-session applications ran from 2 March to 15 June 2026. Art. 5 of the decree sets three components for pharmacy: a written examination, an oral examination and a practical examination. Tested areas span pharmacology, pharmacotherapy, clinical pharmacy, pharmaceutics, medicinal chemistry, pharmacognosy, and pharmacy law and ethics. Passing the Colloquium is a statutory condition of licensure under Law No. 367/1994 (Art. 3), alongside registration with the Order of Pharmacists of Lebanon. This bank provides 100 English-language study questions and covers only the knowledge layer of the written component.
Time Limit
Not published in the DGHE notices; the oral and practical examinations are scheduled on separate session dates
Passing Score
Decree No. 9276 (Art. 5): at least 12/20 on the written paper to sit the oral and practical examinations, at least 12/20 overall across the three components, and not less than 8/20 on the practical examination
Exam / Certification Fees
A lump-sum registration fee collected by MEHE and fixed by decree taken in the Council of Ministers (Law No. 367/1994, Art. 94); the amount is not published in the statute. MEHE launched electronic payment of Colloquium fees in July 2026
Exam sponsor websiteFees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.
Our practice resources: topics covered
We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.
Pharmacology & Pharmacotherapy
Mechanism of action, therapeutic regimens, adverse effects, and contraindications across major drug classes and disease states.
Clinical Pharmacy, Patient Care & Toxicology
Therapeutic drug monitoring, drug interactions, renal/hepatic dose adjustments, toxic syndromes and antidotes, and patient counseling.
Pharmaceutics & Biopharmaceutics
Formulation science, drug absorption and bioavailability, clearance kinetics, half-life calculations, and physical chemical stability.
Medicinal Chemistry & Pharmacognosy
Chemical structures, functional group properties, metabolic transformation pathways, bioactive phytoconstituents, and herbal safety.
Pharmacy Law, Ethics & Public Health
Lebanese pharmaceutical regulations, controlled substances schedules, prescription handling, OPL professional ethics, and public health.
Preparing for the Lebanon Pharmacy Colloquium Exam
What You Need to Know
- Passing score: Decree No. 9276 (Art. 5): at least 12/20 on the written paper to sit the oral and practical examinations, at least 12/20 overall across the three components, and not less than 8/20 on the practical examination
- Assessment: The Lebanese Pharmacy Colloquium (Colloque de Pharmacie) is organised by the Ministry of Education and Higher Education with the Ministry of Public Health, and conducted by the Lebanese University Faculty of Pharmacy under Decree No. 9276 (Art. 4). It runs in two sessions per year (first and second session) whose dates are fixed by DGHE circular; for 2026, first-session applications ran from 2 March to 15 June 2026. Art. 5 of the decree sets three components for pharmacy: a written examination, an oral examination and a practical examination. Tested areas span pharmacology, pharmacotherapy, clinical pharmacy, pharmaceutics, medicinal chemistry, pharmacognosy, and pharmacy law and ethics. Passing the Colloquium is a statutory condition of licensure under Law No. 367/1994 (Art. 3), alongside registration with the Order of Pharmacists of Lebanon. This bank provides 100 English-language study questions and covers only the knowledge layer of the written component.
- Time limit: Not published in the DGHE notices; the oral and practical examinations are scheduled on separate session dates
- Exam / certification fees: A lump-sum registration fee collected by MEHE and fixed by decree taken in the Council of Ministers (Law No. 367/1994, Art. 94); the amount is not published in the statute. MEHE launched electronic payment of Colloquium fees in July 2026 Official sources
Using Our Practice Resources
- Work through all 100 available questions
- Review every answer and explanation
- Track weak areas and revisit them
- Use our AI tutor for tough concepts
Lebanon Pharmacy Colloquium: Suggested Study Strategy
Frequently Asked Questions
What does the Lebanese Pharmacy Colloquium examination consist of?
Decree No. 9276 (Art. 5) sets three components for pharmacy: a written examination, an oral examination and a practical examination. Only candidates scoring at least 12/20 on the written paper may sit the oral and practical examinations, and the practical mark must not fall below 8/20 for a final pass.
Who is required to sit for the Pharmacy Colloquium?
Decree No. 9276 (Art. 5) subjects holders of a pharmacy degree from faculties and institutes operating in Lebanon and abroad, without exception, to the Colloquium, and Law No. 367/1994 (Art. 3) makes passing it a condition of the practice licence alongside registration with the Order of Pharmacists of Lebanon. Degrees obtained by correspondence study are not admitted to the examination.
In what languages is the exam administered?
Candidates may take the official exam in English or French according to the primary language of instruction at their degree-granting institution. This question bank is an English-language study adaptation developed by OpenExamPrep.
When are the Pharmacy Colloquium sessions held?
The Directorate General of Higher Education runs two sessions per year, announced as the first session (الدورة الأولى) and the second session (الدورة الثانية). Dates are set by circular rather than by fixed calendar months: for 2026, first-session applications were accepted from 2 March to 15 June 2026, with university-equivalency files due by 30 April 2026.
How are registration fees paid for the exam?
Law No. 367/1994 (Art. 94) requires MEHE to collect a lump-sum registration fee from every Colloquium candidate, with the amount fixed by decree taken in the Council of Ministers. Candidates must pay within one week of their application being accepted, and MEHE announced the move of Colloquium services to electronic fee payment in July 2026.